Publications by authors named "Naveen Manchanda"

Mastocytosis is a heterogeneous group of disorders comprising cutaneous mastocytosis, systemic mastocytosis, and mast cell sarcoma. It is associated with a variety of symptoms related to the release of mast cell mediators and mast cell tissue infiltration. Referral to specialized centers with expertise in the management of mastocytosis and multidisciplinary collaboration with subspecialists (eg, allergists for the management of anaphylaxis and drug hypersensitivities, anesthesiologists for invasive procedures or surgery, high-risk obstetrician for pregnancy) is recommended.

View Article and Find Full Text PDF

Unlabelled: This study aimed to comprehensively analyze inflammatory and autoimmune characteristics of patients with sickle cell disease (SCD) at a steady-state condition (StSt) compared to healthy controls (HCs) to explore the pathogenesis of StSt and its impact on patients' well-being. The study cohort consisted of 40 StSt participants and 23 HCs enrolled between July 2021 and April 2023. StSt participants showed elevated white blood cell (WBC) counts and altered hematological measurements when compared to HCs.

View Article and Find Full Text PDF

This study aimed to comprehensively analyze inflammatory and autoimmune characteristics of patients with sickle cell disease (SCD) at a steady-state condition (StSt) compared to healthy controls (HCs) to explore the pathogenesis of StSt and its impact on patients' well-being. The study cohort consisted of 40 StSt participants and 23 HCs enrolled between July 2021 and April 2023. StSt participants showed elevated white blood cell (WBC) counts and altered hematological measurements when compared to HCs.

View Article and Find Full Text PDF
Article Synopsis
  • Epstein-Barr virus (EBV) often remains latent in individuals after initial infection, but can reactivate in immunosuppressed people, leading to serious conditions like lymphomas and gastritis.
  • A case study details a 65-year-old woman with polycythemia vera who developed EBV gastritis and viremia, which improved after adjusting her medication and starting antiviral treatment.
  • The report highlights the need for early diagnosis of EBV gastritis in immunocompromised patients and suggests that treatment should include stopping immunosuppressive therapy, using antivirals, and monitoring for possible EBV-related cancers.
View Article and Find Full Text PDF

Interest in an oncology career has decreased among internal medicine residents completing an inpatient hematology-oncology rotation. Over years, our institutional data at Indiana University School of Medicine reflected lower satisfaction with the oncology inpatient ward rotation as compared to other rotations. We hypothesized that a switch from an inpatient ward rotation to a hybrid model of inpatient consultations and outpatient clinics would improve resident satisfaction with their educational experience in oncology.

View Article and Find Full Text PDF

Introduction: Mini-Gastric Bypass (MGB) is becoming more and more popular as shown by the numerous articles published over the past 15 years, supporting the operation as a short and simple procedure with excellent outcomes and low complication rates. There is still confusion amongst surgeons on the technique of the operation. The purpose of this paper is to review and describe the technique of MGB by its originators.

View Article and Find Full Text PDF
Article Synopsis
  • Mini-gastric bypass (MGB) is a safe and effective treatment for patients with type II diabetes and obesity, but its long-term effects for those with a BMI under 35 kg/m² are less understood.
  • A study of 128 patients with BMI 30-35 kg/m² showed significant improvements in diabetes management, with a 95% rate achieving an HbA1c <7% within 6 months and strong remission rates over several years.
  • MGB significantly lowered HbA1c levels over time and resulted in no deaths, though a small percentage faced major complications, highlighting the benefits of early intervention for better long-term outcomes in diabetes control.
View Article and Find Full Text PDF

Urokinase plasminogen activator receptor (u-PAR) binds urokinase plasminogen activator (u-PA) and participates in plasminogen activation in addition to modulating several cellular processes such as adhesion, proliferation, and migration. u-PAR is susceptible to proteolysis by its cognate ligand and several other proteases. To elucidate the biological significance of receptor cleavage by u-PA, we engineered and expressed a two-chain urokinase plasminogen activator (tcu-PA) cleavage-resistant u-PAR (cr-u-PAR).

View Article and Find Full Text PDF